Extended-release carbamazepine capsules as monotherapy in bipolar disorder: Pooled results from two randomised, double-blind, placebo-controlled trials Review uri icon

Overview

MeSH Major

  • Anticonvulsants
  • Bipolar Disorder
  • Carbamazepine
  • Clinical Trials as Topic
  • Randomized Controlled Trials as Topic

abstract

  • These results confirm previous findings that CBZ-ERC is effective in the treatment of bipolar I disorder patients with either acute manic or mixed episodes. These data suggest that further randomised controlled studies are warranted to delineate the effect of CBZ-ERC on depressive symptoms in patients with bipolar disorder.

publication date

  • March 20, 2006

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.2165/00023210-200620030-00004

PubMed ID

  • 16529527

Additional Document Info

start page

  • 219

end page

  • 31

volume

  • 20

number

  • 3